Similar articles

• Recent experience in prenatal fra(X) detection.

  Jenkins EC, Brown WT, Krawczun MS, Duncan CJ, Lele KP, Cantu ES, Schonberg S, Golbus MS, Sekhon GS, Stark S, et al. Jenkins EC, et al. Am J Med Genet. 1988 May-Jun;30(1-2):329-36. doi: 10.1002/ajmg.1320300133. Am J Med Genet. 1988. PMID: 2972205
• Improved prenatal detection of fra(X)(q27.3): methods for prevention of false negatives in chorionic villus and amniotic fluid cell cultures.

  Jenkins EC, Krawczun MS, Stark-Houck SL, Duncan CJ, Kunaporn S, Gu H, Schwartz-Richstein C, Howard-Peebles PN, Gross A, Sherman SL, et al. Jenkins EC, et al. Am J Med Genet. 1991 Feb-Mar;38(2-3):447-52. doi: 10.1002/ajmg.1320380262. Am J Med Genet. 1991. PMID: 1826813
• Prenatal diagnosis of the fragile X syndrome: possible end of the experimental phase for amniotic fluid.

  Shapiro LR, Wilmot PL, Murphy PD. Shapiro LR, et al. Am J Med Genet. 1991 Feb-Mar;38(2-3):453-5. doi: 10.1002/ajmg.1320380263. Am J Med Genet. 1991. PMID: 1673318
• Access to the fetus.

  Daffos F. Daffos F. Nouv Rev Fr Hematol (1978). 1990;32(6):431-3. Nouv Rev Fr Hematol (1978). 1990. PMID: 2101875 Review. No abstract available.
• Prenatal diagnostic procedures.

  D'Alton ME. D'Alton ME. Semin Perinatol. 1994 Jun;18(3):140-62. Semin Perinatol. 1994. PMID: 7973784 Review.